Cash and cash equivalents Cash and Cash Equivalent CONTIGENT LIABILITIES AND COMMITMENTS Commitments and Contingencies Ordinary shares of no-par value - Authorized: 30,000,000 and 14,000,000 shares at June 30, 2026 and December 31, 2025, respectively; Issued and outstanding: 4,285,093 and 2,618,425 shares as of June 30, 2026 and December 31, 2025, respectively Common Stock, Value, Issued Deferred revenues Contract with Customer, Liability, Current Deferred revenues Contract with Customer, Liability, Noncurrent Short term deposits Deposits Assets, Current Total liabilities and shareholders’ equity Liabilities and Equity Total current liabilities Liabilities, Current CURRENT LIABILITIES: Liabilities, Current [Abstract] Total long-term liabilities Liabilities, Noncurrent NON-CURRENT LIABILITIES: Liabilities, Noncurrent [Abstract] Current maturity of operating lease liability Operating Lease, Liability, Current Long - term operating lease liability Operating Lease, Liability, Noncurrent Operating lease right of use assets Operating Lease, Right-of-Use Asset Prepaid expenses and other current assets Prepaid Expense and Other Assets, Current Property, plant and equipment, net Property, Plant and Equipment, Net Accumulated deficit Retained Earnings (Accumulated Deficit) Short-term investment Short-Term Investments Statement of Financial Position [Abstract] Total shareholders’ equity Balance Balance Equity, Attributable to Parent SHAREHOLDERS’ EQUITY: Equity, Attributable to Parent [Abstract] Ordinary shares, par value (in Dollars per share) Common Stock, Par or Stated Value Per Share Ordinary shares, shares authorized Common Stock, Shares Authorized Ordinary shares, shares issued Common Stock, Shares, Issued Ordinary shares, shares outstanding Common Stock, Shares, Outstanding Basic net loss per share (in Dollars per share) Net loss per share of Ordinary Share, basic Earnings Per Share, Basic Diluted net loss per share (in Dollars per share) Net loss per share of Ordinary Share, diluted Earnings Per Share, Diluted General and administrative expenses General and Administrative Expense Income Statement [Abstract] Financial income, net Investment Income, Net Operating loss Net losses Net loss Operating loss Net loss applicable to shareholders of Ordinary Shares Net Income (Loss) Attributable to Parent Operating loss Operating Income (Loss) Research and development expenses Research and Development Expense Revenues Revenues Weighted average number of ordinary shares used in computing diluted net loss per share Weighted average shares used in computing diluted net loss per share Weighted Average Number of Shares Outstanding, Diluted Weighted average number of ordinary shares used in computing basic net loss per share Weighted average shares used in computing basic net loss per share Weighted Average Number of Shares Outstanding, Basic Issuance of ordinary shares due to ATM, net of issuance costs Issuance Of Ordinary Shares Due To ATMNet Of Issuance Costs Issuance of ordinary shares due to ATM, net of issuance costs. Issuance of ordinary shares and warrants, net of issuance costs (in Shares) Stock Issued During Period Share Issuance Of Share Capital And Warrants Number of issuance of share capital and warrants, net of issuance expenses. Issuance of ordinary shares due to ATM, net of issuance costs (in Shares) Stock Issued During Period Shares Issuance Of Ordinary Shares Due To ATM Represent the number of shares issuance of ordinary shares due to ATM. Issuance of ordinary shares and warrants, net of issuance costs Stock Issued During Period Value Issuance Of Share Capital And Warrants Issuance of share capital and warrants, net of issuance expenses. Accumulated other comprehensive income AOCI Attributable to Parent [Member] Significant Accounting Policies [Abstract] Revenue Recognition – Contract Balances Revenue from Contract with Customer [Policy Text Block] FAIR VALUE MEASUREMENTS Fair Value Disclosures [Text Block] CONTINGENT LIABILITIES AND COMMITMENTS Commitments and Contingencies Disclosure [Text Block] Issuance of ordinary shares, net of issuance costs (in Shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period Shareholders' Equity [Abstract] Net cash (provided by) used in investing activities Cash Provided by (Used in) Investing Activity, Including Discontinued Operation Contingent Liabilities and Commitments [Abstract] SHAREHOLDERS’ EQUITY Equity [Text Block] Recognized revenues Contract with Customer, Liability, Revenue Recognized Contract liabilities Contract with Customer, Liability General [Abstract] Net operating cash outflow Net cash used in operating activities Cash Provided by (Used in) Operating Activity, Including Discontinued Operation Cash and cash equivalents Cash Equivalents, at Carrying Value Number of ordinary shares in each ADS (in Shares) Number Of Ordinary Shares The number of ordinary shares. Schedule of Information Regarding Outstanding Warrants to Purchase Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block] Schedule of Fair Value of Company's Share Options Granted Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Weighted average remaining contractual terms Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Maximum [Member] Maximum [Member] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Expected volatility Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate Contractual life (in years) Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term Exercise price (NIS) (in New Shekels per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Exercise Price Schedule of Weighted Average Exercise Prices Share Options [Abstract] Weighted average exercise price, Grants Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Weighted average exercise price, expired Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price Weighted average exercise price, Vested and expected to vest Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price Aggregate intrinsic value, Vested and expected to vest (in Dollars) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value Statistical Measurement [Domain] Minimum [Member] Minimum [Member] Statistical Measurement [Axis] Number of options, Exercisable (in Shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number Weighted average remaining contractual terms, Exercisable Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term Number of options, Ending (in Shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Weighted average exercise price, Exercisable Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price Aggregate intrinsic value, Exercisable (in Dollars) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value Weighted average remaining contractual terms, expired Sharebased Compensation Arrangement By Sharebased Payment Award Options Weighted Average Remaining Contractual Terms Forfeitedexpired Share based compensation arrangement by share based payment award, options, nonvested options forfeited, weighted average grant date fair value. Weighted average of the grant date fair value, Grants ShareBasedCompensationArrangementByShareBasedPaymentAwardWeightedAverageOfTheGrantDateFairValueGrants The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology. Par value shares Common Stock, No Par Value Inducement Letter [Member] Sale of Stock [Axis] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Warrant [Member] Warrants [Member] Schedule Of Fair Value Of Company SShare Options Granted Abstract Early Exercise Multiple (Suboptimal Factor) Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumption Exercise Price Agreed-upon price for the exchange of the underlying asset relating to the share-based payment award. Shareholders' Equity - Schedule of Fair value of Company’s Share Options Granted (Details) [Table] Number of shares Number of Shares The number of ordinary shares. Ordinary share, voting rights Common Stock, Voting Rights Ordinary Shares [Member] Ordinary shares Common Stock [Member] Ordinary shares reserved for issuance Common Stock, Capital Shares Reserved for Future Issuance Warrants to purchased ordinary shares Warrant purchase Class of Warrant or Right, Number of Securities Called by Warrants or Rights Exercise price per warrant (in Dollars per share) Exercise price per share Class of Warrant or Right, Exercise Price of Warrants or Rights Class of Warrant or Right [Domain] Shares granted Number of options, Grants (in Shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross Sale of Stock [Domain] Equity issuance cost Proceeds from Issuance or Sale of Equity, Total Gross proceeds Proceeds from Issuance of Warrants Plan Name [Domain] Plan Name [Axis] Net of issuance expenses of ordinary shares due to exercise of warrants Net of Issuance Expenses of Ordinary Shares Due to Exercise of Warrants Represent the amount of net of issuance expenses of ordinary shares due to exercise of warrants. Net of issuance costs ordinary shares due to ATM Net of Issuance Costs Ordinary Shares Due To ATM Represent the amount of net of issuance costs ordinary shares due to ATM. Research and Development [Member] General and Administrative [Member] Statement of Income Location Balance [Axis] Income Statement Location [Domain] Class of Warrant or Right [Table] Award Date [Domain] November 2023 [Member] November Two Thousand Twenty Three [Member] Issuance date Issuance Date Represent the date of issuance. April 2025 [Member] April Two Thousand Twenty Five [Member] Scenario [Axis] Scenario [Domain] Definitive Agreement [Member] Statement of Stockholders' Equity [Abstract] Net of issuance costs of ordinary shares and warrants Net of Issuance Costs of Ordinary Shares and Warrants Represent the amount of net of issuance costs of ordinary shares and warrants. Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Registrant Name Document Period End Date Document Period End Date Numerator: Net Income (Loss) Attributable to Parent [Abstract] Subsequent Events [Abstract] Subsequent Events [Line Items] Warrants represented Class of Warrant or Right, Number of Securities Called by Each Warrant or Right Other accounts payable Accounts Payable, Other, Current Trade payables Accounts Payable, Trade, Current Accumulated other comprehensive income Accumulated Other Comprehensive Income (Loss), Net of Tax Additional paid-in capital Additional Paid in Capital, Common Stock Total assets Assets Total current assets Assets, Current CURRENT ASSETS: Assets, Current [Abstract] Total non-current assets Assets, Noncurrent NON-CURRENT ASSETS: Assets, Noncurrent [Abstract] SUBSEQUENT EVENTS Subsequent Events [Text Block] Financial expenses (income), net Other Noncash Income (Expense) Share-based payments APIC, Share-Based Payment Arrangement, Option, Increase for Cost Recognition Balance (in Shares) Balance (in Shares) Shares, Outstanding Statement [Table] Issuance of ordinary shares, net of issuance costs Stock Issued During Period, Value, Stock Options Exercised Exchange differences on balances of cash and cash equivalents Effect of Exchange Rate on Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation Cash and cash equivalents at the beginning of the period Cash and cash equivalents at the end of the period Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation Statement of Cash Flows [Abstract] Reduction in the carrying amount of operating lease right of use asset Operating Lease, Right-of-Use Asset, Periodic Reduction Changes in fair value of short-term investment Changes In Fair Value Of Short Term Investment Represent the amount of changes in fair value of short term investment. Change in prepaid expenses, and other current assets Increase (Decrease) in Prepaid Expense and Other Assets Decrease (increase) in trade payables Increase (Decrease) in Accounts Payable, Trade Decrease in other accounts payable Increase (Decrease) in Other Accounts Payable Cash flows from investing activities: Cash Provided by (Used in) Investing Activity, Including Discontinued Operation [Abstract] Maturity (investment) in short term deposits, net Payments for (Proceeds from) Short-Term Investments Cash flows from operating activities: Cash Provided by (Used in) Operating Activity, Including Discontinued Operation [Abstract] Purchase of property, plant and equipment Payments to Acquire Property, Plant, and Equipment Decrease in deferred revenues Increase (Decrease) in Deferred Revenue Decrease in operating lease liability Increase (Decrease) in Operating Lease Liability Share-based payments Share-Based Payment Arrangement, Noncash Expense Statement [Line Items] Accumulated deficit Retained Earnings [Member] Additional  paid-in capital Additional Paid-in Capital [Member] Equity Components [Axis] Fair Value Measurements [Abstract] SIGNIFICANT ACCOUNTING POLICIES Significant Accounting Policies [Text Block] Increase (decrease) in cash and cash equivalents Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation Net cash provided by financing activities Cash Provided by (Used in) Financing Activity, Including Discontinued Operation Proceeds from issuance of ordinary shares due to ATM, net of issuance costs Proceeds from Issuance of Common Stock Depreciation of property, plant and equipment Depreciation, Depletion and Amortization Proceeds from issuance of ordinary shares, net of issuance costs Amount of proceeds from issuance of ordinary shares, net of issuance costs. Adjustments required to reconcile net loss to net cash used in operating activities: Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity [Abstract] Equity Component [Domain] Cash flows from financing activities: Cash Provided by (Used in) Financing Activity, Including Discontinued Operation [Abstract] Share-based payments (in Shares) Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture GENERAL Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Schedule of Company’s Options Activity Share-Based Payment Arrangement, Option, Activity [Table Text Block] Schedule of Expenses Recognized in the Financial Statements Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block] Schedule of Financial Assets and Liabilities Measured at Fair Value on a Recurring Basis Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] Existing Warrants [Member] Weighted average exercise price, Ending Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Risk-free interest rate Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Number of ordinary shares Stock Issued During Period, Shares, Period Increase (Decrease) Exercise price, per share Stock Option, Exercise Price, Increase Aggregate intrinsic value, Ending (in Dollars) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value Number of options, Vested and expected to vest (in Shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number Weighted average remaining contractual terms, Vested and expected to vest Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term Dividend yield Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate Weighted average remaining contractual terms, Grants Sharebased Compensation Arrangement By Sharebased Payment Award Options Terms Grants Weighted average remaining contractual term for vested portions of options Grants, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Number of options, expired Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period Ordinary shares issue (in Shares) Stock Issued During Period, Shares, New Issues Other fees Other Underwriting Expense Percentage of management fee Percentage of management fee Percentage of management fee. Weighted average of the grant date fair value, Ending ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageDateFairValue The weighted average grant-date fair value of options during the reporting period as calculated by applying the disclosed option pricing methodology. Weighted average of the grant date fair value, Vested and expected to vest ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageOfTheGrantDateFairValueVestedAndExpectedToVest Represent the weighted average of the grant date fair value, Vested and expected to vest. Weighted average of the grant date fair value, Exercisable ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageOfTheGrantDateFairValueExercisable The weighted average of the grant date fair value as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan. Reverse split ratio Stockholders' Equity, Reverse Stock Split Class of Stock [Axis] Fair Value Measurements - Schedule of Financial Assets and Liabilities Measured at Fair value Recurring Basis (Details) [Table] Schedule Of Financial Assets And Liabilities Measured At Fair Value Recurring Basis Abstract Schedule of Financial Assets and Liabilities Measured at Fair value Recurring Basis [Line Items] Fair Value Hierarchy and NAV [Axis] Measurement Frequency [Axis] Level 1 [Member] Fair Value, Inputs, Level 1 [Member] Level 2 [Member] Fair Value, Inputs, Level 2 [Member] Level 3 [Member] Fair Value, Inputs, Level 3 [Member] Measurement Frequency [Domain] Fair Value Hierarchy and NAV [Domain] Fair Value, Recurring [Member] Contingent Liabilities and Commitments (Details) [Table] Percentage of net sales Percentage Of Net Sales The percentage of net sales. Phase III Studies [Member] Phase IIIStudies Member Phase II Studies [Member] Phase IIStudies Member Phase I Studies [Member] Phase IStudies Member Regulatory Authority [Member] Regulatory Authority Member Royalty payments, percentage Royalty Payments Percentage The royalty payment in percentage. Accrual Accrual for Taxes Other than Income Taxes Award Type [Axis] Concession commission Noninterest Expense Commission Expense Contingent Liabilities and Commitments [Line Items] Royalties Royalty Expense Award Type [Domain] American Depositary Shares (ADSs) [Member] American Depositary Shares Member Aggregate warrants percentage Class Of Warrant Or Right Percentage Class of Warrant or Right, Percentage Granted excess years Granted Excess Years Granted excess years. New Warrants [Member] Shareholders' Equity (Details) [Table] Special General Meeting of Shareholders [Member] 2013 Plan [Member] Two Thousand Thirteen Plan Member 2023 Plan [Member] Two Thousand Twenty Three Plan Member Board of Directors [Member] Board of Directors Chairman [Member] Title and Position [Axis] Title and Position [Domain] Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Class of Stock [Domain] Shareholders' Equity [Line Items] Class of Warrant or Right [Axis] Denominator: Weighted Average Number of Shares Outstanding, Diluted [Abstract] Schedule of Expenses Recognized Financial Statements [Abstract] Share based expenses Share-Based Payment Arrangement, Expense Schedule of Share-Based Payment Arrangement Expensed [Line Items] Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table] Award Date [Axis] Schedule Of Information Regarding Outstanding Warrants To Purchase Abstract November 2023 agent [Member] July 2025 [Member] July Two Thousand Twenty Five [Member] January 2023 agent [Member] August 2024 [Member] August Two Thousand Twenty Four [Member] August 2024 agent [Member] Number of outstanding Warrants Class of Warrant or Right, Outstanding Schedule of Outstanding Warrants to Purchase Shares [Line Items] New Warrant Shares [Member] Document Information [Line Items] Document Type Document Type Earning Per Share [Abstract] EARNING PER SHARE Earnings Per Share [Text Block] Schedule of Computation of Basic and Diluted Net Loss Per Share Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Schedule of Computation of Diluted Net Loss Per Share Attributable to Ordinary Shareholders Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] March 30 2026 [Member] March 30 2026 agent [Member] Schedule of Computation of Diluted Net Loss Per Share Attributable to Ordinary Shareholders [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Potential shares of ordinary shares Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Antidilutive Security, Excluded EPS Calculation [Table] Antidilutive Securities [Axis] Antidilutive Securities, Name [Domain] Options [Member] Share-Based Payment Arrangement, Option [Member] Subsequent Events (Details) [Table] ADS [Member] ADSMember American Depository Receipt (or American Depository Share, ADS). Forecast [Member] Document Information [Table] Entity Central Index Key Entity Central Index Key Document Fiscal Year Focus Document Fiscal Year Focus Amendment Flag Amendment Flag Document Fiscal Period Focus Document Fiscal Period Focus